Stock listing
A2N6VA Stock Price, News, Filings & Events — Medincell Sa
Selected listing: A2N6VA · LS · EUR · DE
This page tracks Medincell Sa's A2N6VA:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2N6VA:LS. A2N6VA:LS is the stock-level entry point for investors researching Medincell Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2N6VA:LS
- Asset type
- Stock
- Market cap
- $909.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Medincell Sa A2N6VA:LS stock context
This page tracks Medincell Sa's A2N6VA:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2N6VA:LS. A2N6VA:LS is the stock-level entry point for investors researching Medincell Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Medincell Sa
Medincell to Participate in Upcoming Investor Conferences
September 9, 2026
Medincell: Publication of the Notice of Meeting and Reminder of the Participation terms in the Combined General Meeting
September 8, 2026
Medincell Appoints Edna Venneker, MD, as Chief Medical Officer
September 1, 2026
Medincell: UZEDY®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook
July 29, 2026
Medincell Continues to Strengthen and Renew Its Board of Directors with the Proposed Appointment of Dr. Elisabeth Svanberg
July 28, 2026
Medincell Sa earnings calls
Research Medincell Sa
Medincell Sa investor report
Review AI stock analysis and investor report context for A2N6VA:LS.
Medincell Sa company profile
View the public company page for Medincell Sa on 6ix.
Medincell Sa news
Read company news and market updates connected to Medincell Sa.
Medincell Sa investor events
Find investor webinars, events, and replay context for Medincell Sa.
Alternate listings
MEDCL:EURONEXT
FR · EUR
Alternate listing for Medincell Sa; the primary context on this page is A2N6VA:LS.
MEB:GETTEX
DE · EUR
Alternate listing for Medincell Sa; the primary context on this page is A2N6VA:LS.
0ACH:LSE
GB · EUR
Alternate listing for Medincell Sa; the primary context on this page is A2N6VA:LS.
MEB:TRADEGATE
DE · EUR
Alternate listing for Medincell Sa; the primary context on this page is A2N6VA:LS.
A2N6VA:LSX
DE · EUR
Alternate listing for Medincell Sa; the primary context on this page is A2N6VA:LS.
MDCLF:OTC
US · USD
Alternate listing for Medincell Sa; the primary context on this page is A2N6VA:LS.
MEB:FWB
DE · EUR
Alternate listing for Medincell Sa; the primary context on this page is A2N6VA:LS.
MEDCL:BX
CH · CHF
Alternate listing for Medincell Sa; the primary context on this page is A2N6VA:LS.
MEDCLP:TURQUOISE
GB · EUR
Alternate listing for Medincell Sa; the primary context on this page is A2N6VA:LS.
MEB:HAM
DE · EUR
Alternate listing for Medincell Sa; the primary context on this page is A2N6VA:LS.
MEB:SWB
DE · EUR
Alternate listing for Medincell Sa; the primary context on this page is A2N6VA:LS.
MEDCLP:AQUISEU
GB · EUR
Alternate listing for Medincell Sa; the primary context on this page is A2N6VA:LS.